The Lynx Group

Best Practices: Biomarkers

Best Practices: Biomarkers and Treatment Selection in the Management of Advanced NSCLC

Wallace Akerley, MDProfessor of Medicine Thoracic Oncology Huntsman Cancer Institute at University of Utah Salt Lake City, UT Katie Kerrigan, DO Assistant Professor of Internal Medicine Division of Medical Oncology Huntsman Cancer Institute at University of Utah Salt Lake City, UT Introduction Immune checkpoint inhibitors (ICIs) have revolutionized the treatment [ Read More ]

Sign me up!